Q-Line Biotech IPO: Fully Priced Offering Raises Eyebrows Amidst Financial Inconsistencies
Q-Line Biotech's IPO is opening soon, seeking to raise over Rs. 200 crore. While it operates in the diagnostics sector, a closer look reveals financial inconsistencies and high debt levels. Discover the key concerns investors must consider before subscribing.
